The Menopause Cocktail: Why Doctors Are Combining Allergy Meds with HRT
As clinical data validates off-label combinations, a viral trend is reshaping how severe hot flashes are treated.
Browse the latest Tikva reporting, guides, and practical explanations.
As clinical data validates off-label combinations, a viral trend is reshaping how severe hot flashes are treated.
The FOMC wraps its July meeting with rates at 3.5%–3.75%. Here's what Jerome Powell's next move means for your savings, CDs, and mortgage.
With a projected 3.8% Social Security bump for 2027, now is the window to accelerate Roth conversions and fix expenses before tax brackets tighten.
Exercise triggers a liver enzyme that repairs the blood-brain barrier—offering a concrete, drug-free lever against dementia
Columbia scientists reveal serotonin can accelerate mitral valve disease in patients with a specific genetic variant — and common SSRIs may fan the flames.
OpenAI's three-tiered GPT-5.6 family is confusing everyday users. We cut through the benchmarks, API costs, and agentic jargon.
A stark divergence in Q2 earnings exposes which Mag 7 narratives are holding water—and which are leaking cash.
The FDA just greenlit the first over-the-counter fixed-dose combo of acetaminophen and naproxen sodium. Here's the clinical data, the dosing math, and the risk profile.
A 50% tariff on $20 billion in Canadian imports takes effect August 19, 2026. Here's what the data says about the coming hit to vehicles, dairy, and alcohol.
As trillion-dollar AI valuations face market scrutiny, Bloomberg's Karen Hao argues the current model is fundamentally flawed—built on unsustainable power grabs, exploited labor, and economics that don't add up.